OptimizeRx Corp
Expected move
InputsNext report
Last report
Largest filed tie
—
13F top-10 QoQ
Top fund weight
Last report6 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
OptimizeRx Corp
9.22
+24.72%
vs ±15.0% implied · ×1.65
shaded = implied · ▲▼ = realized
No thesis.
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Whetstone Capital AdvisorsWhetstone Capital | $8.6M | 13.29% | 0.00% | |
| 2 | Royce & AssociatesRoyce & | $6.2M | 9.60% | +22.68% | |
| 3 | Vanguard Capital ManagementVanguardindex-like | $4.0M | 6.16% | +2.07% | |
| 4 | Kennedy Capital ManagementKennedy | $3.7M | 5.67% | −1.85% | |
| 5 | Rice Hall James & AssociatesRice Hall James & | $3.6M | 5.58% | +5.30% | |
| 6 | Blair WilliamBlair William | $3.5M | 5.36% | −1.15% | |
| 7 | AQR Capital ManagementAQR | $3.3M | 5.14% | +171.67% | |
| 8 | Dimensional Fund AdvisorsDimensional | $2.7M | 4.21% | −15.24% | |
| 9 | BlackRockBlackRockindex-like | $2.5M | 3.92% | −61.72% | |
| 10 | Parkman Healthcare PartnersParkman Healthcare Partners | $2.0M | 3.09% | −51.97% | |
| 11 | Bullseye Asset ManagementBullseye | $1.5M | 2.28% | +14.03% | |
| 12 | AWM InvestmentAWM Investment | $1.4M | 2.12% | +4.34% | |
| 13 | Citadel AdvisorsCitadel | $1.2M | 1.88% | +358.23% | |
| 14 | Geode Capital ManagementGeodeindex-like | $1.2M | 1.83% | −47.12% | |
| 15 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $969,757 | 1.49% | −48.79% | |
| 16 | Renaissance TechnologiesRenaissance Technologies | $959,244 | 1.48% | −22.67% | |
| 17 | Marshall WaceMarshall Wace | $927,704 | 1.43% | +418.40% | |
| 18 | P.A.W. CapitalP.A.W. Capital | $915,200 | 1.41% | +77.78% | |
| 19 | Jane Street GroupJane Street | $915,120 | 1.41% | +488.18% | |
| 20 | Morgan StanleyMorgan Stanley | $894,116 | 1.38% | +104.69% | |
| 21 | Mink Brook Asset ManagementMink Brook | $807,864 | 1.24% | new | |
| 22 | D. E. ShawD. E. Shaw | $789,840 | 1.22% | −3.39% | |
| 23 | Janney Montgomery ScottJanney Montgomery Scott | $778,000 | 1.20% | new | |
| 24 | Goldman Sachs GroupGoldman Sachs | $600,812 | 0.93% | −70.70% | |
| 25 | Quantinno Capital ManagementQuantinno | $566,989 | 0.87% | +102.20% |
112 managers report $64.9M of OptimizeRx on form 13F for the quarter ended Jun 30 '26. 22 of them hold 80% of it; Whetstone Capital is largest at 13.29%.
Expected move
Inputs8Q avg ±26.9%·×0.38·cheap
straddle ±15.3%
spot 9.32exp Nov 20ATM strike 10ATM straddle 1.68IV 86%